tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
XENE is currently covered by 10 analysts with an average price target of $74.85. This is a potential upside of $17.25 (18.47%) from yesterday's end of day stock price of $63.18.
Xenon Pharmaceuticals's activity chart (see below) currently has 114 price targets and 109 ratings on display. The stock rating distribution of XENE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 90.38% with an average time for these price targets to be met of 522.54 days.
Highest price target for XENE is $97, Lowest price target is $55, average price target is $74.85.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 07-Aug-2026. First documented stock forecast 01-Dec-2014.
Currently out of the existing stock ratings of XENE, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Oct-2021
$81
$18.65 (29.91%)
$82
Buy Since 21-Jul-2022
$82
$22.26 (37.26%)
$80
Buy Since 21-Jul-2020
$78
$18.26 (30.57%)
$80
Buy Since 25-Mar-2020
$63
$3.26 (5.46%)
$64
Buy Since 04-Jan-2024
$90
$30.26 (50.65%)
$60
What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?
